![Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer - Annals of Oncology Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9f012fd7-2d34-4aed-be3f-50d7daf97db4/gr1_lrg.jpg)
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer - Annals of Oncology
![Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26d9baf973907a54e3ab94697b7c0d6e648f2245/2-TableI-1.png)
Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar
![Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis | Nature Communications Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-019-12412-1/MediaObjects/41467_2019_12412_Fig1_HTML.png)
Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis | Nature Communications
![Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study | HTML Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study | HTML](https://www.mdpi.com/cancers/cancers-11-00733/article_deploy/html/images/cancers-11-00733-g001-550.jpg)
Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study | HTML
![A retrospective analysis of serum tumor markers found in non-small cell lung cancer Hu Q, Xiao P, Li J, Yu P - J Can Res Ther A retrospective analysis of serum tumor markers found in non-small cell lung cancer Hu Q, Xiao P, Li J, Yu P - J Can Res Ther](https://www.cancerjournal.net/articles/2016/12/1/images/JCanResTher_2016_12_1_117_151424_t2.jpg)
A retrospective analysis of serum tumor markers found in non-small cell lung cancer Hu Q, Xiao P, Li J, Yu P - J Can Res Ther
![PDF] Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors? | Semantic Scholar PDF] Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/473da07f05acbc0faf8cfff7211cb3844b39f688/4-Table2-1.png)
PDF] Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors? | Semantic Scholar
![Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development | Molecular Cancer | Full Text Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-021-01310-0/MediaObjects/12943_2021_1310_Fig7_HTML.png)
Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development | Molecular Cancer | Full Text
![Premium Photo | Blood sample for cancer marker test or tumor marker test with abnormal laboratory report Premium Photo | Blood sample for cancer marker test or tumor marker test with abnormal laboratory report](https://img.freepik.com/premium-photo/blood-sample-cancer-marker-test-tumor-marker-test-with-abnormal-laboratory-report_595440-1956.jpg?w=2000)
Premium Photo | Blood sample for cancer marker test or tumor marker test with abnormal laboratory report
![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig3_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
![Frontiers | Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors Frontiers | Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors](https://www.frontiersin.org/files/Articles/506801/fonc-10-00739-HTML/image_m/fonc-10-00739-g001.jpg)
Frontiers | Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors
![American Journal of Case Reports | A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy - Article abstract #935207 American Journal of Case Reports | A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy - Article abstract #935207](https://jours.isi-science.com/imageXml.php?i=t2-amjcaserep-23-e935207.jpg&idArt=935207&w=1000)
American Journal of Case Reports | A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy - Article abstract #935207
![IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite | HTML IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite | HTML](https://www.mdpi.com/ijms/ijms-19-01162/article_deploy/html/images/ijms-19-01162-sch003.png)
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite | HTML
![Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected - Clinical Colorectal Cancer Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected - Clinical Colorectal Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/95b7ddcd-fec2-4f23-ae1e-b6157dff8d31/gr1_lrg.jpg)
Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected - Clinical Colorectal Cancer
![Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy | Oncogenesis Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy | Oncogenesis](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41389-022-00400-y/MediaObjects/41389_2022_400_Fig1_HTML.png)